Treatment With Niraparib Maintenance Therapy in Patients With Newly Diagnosed Advanced Ovarian CancerNing Li, Lingying Wu, Jianqing Zhu et al.|JAMA Oncology|2023Cited by 165
Senaparib as first-line maintenance therapy in advanced ovarian cancer: a randomized phase 3 trialXiaohua Wu, Linjuan Zeng, Jihong Liu et al.|Nature Medicine|2024Cited by 41
Assessment Of EZH2 Expression In CD34+ Bone Marrow Progenitor Cells Of Patients Of Myelodysplastic Syndromes (MDS)Yue Wei, Guillermo Garcia‐Manero, Yu Jia et al.|Blood|2013Cited by 0
Association Between Down-Regulation of EZH2 and Abnormal Karyotype, Response to Hypomethylation Treatment, and Patient Survival in Myelodysplastic SyndromesYue Wei, Guillermo Garcia‐Manero, Hui Wang et al.|Blood|2014Cited by 0